Apyx Medical Investors Who Have Suffered Losses Greater Than $50K Encouraged To Contact Kehoe Law Firm, P.C. 

Kehoe Law Firm, P.C. continues its securities investigation on behalf of investors of Apyx Medical Corporation (“Apyx Medical” or the “Company”) (NASDAQ: APYX) to determine whether Apyx Medical issued false or materially misleading business information to the investors.

On March 16, 2020, Apyx Medical announced that its financial statements for the twelve months ended December, 31 2018 and the quarterly statements for the three and nine months ended September 30, 2018 and three months ended March 31, 2019 could no longer be relied upon and, as a result, would need to be restated.

On this news, Apyx Medical’s securities fell $0.23 per share, or more than 5%, to close at $4.36 per share on March 17, 2020.

Apyx Medical investors who purchased, or otherwise acquired, the Company’s common stock and suffered losses greater than $50K are encouraged to contact Kehoe Law Firm, P.C., Kevin Cauley, Director, Business Development, (215) 792-6676, Ext. 802, [email protected][email protected], to discuss the securities investigation or potential legal claims.

Kehoe Law Firm, P.C.